Showing all 11 results
-
-
-
-
-
-
Ngenla 24 mg Somatrogon Prefilled Pen
€ 150,00- Ngenla is a prefilled pen containing somatrogon-ghla, a human growth hormone analog.
- It is used to treat children with growth hormone deficiency.
-
Ngenla 60 mg Somatrogon Prefilled Pen
€ 260,00Quae nihil quia ea vero et quis qui. Iusto ut reiciendis ut deleniti. Itaque occaecati aperiam quas est vel fugiat natus.
-
Ozempic 1mg (semaglutide)
€ 120,00Ozempic (semaglutide) is a prescription medication used for adults with type 2 diabetes to lower their blood sugar levels (A1C). It is also used to reduce the risk of kidney function decline in diabetics with chronic kidney disease (CKD) and lower the risk of heart attack or stroke in certain patients with type 2 diabetes and heart disease.
-
Semaglutide – 5mg
€ 140,00Semaglutide is a medication used for treating type 2 diabetes. It belongs to the class of incretin mimetics, helping to increase insulin production from the pancreas, reduce blood glucose levels, and accelerate metabolism.
Semaglutide is a next-generation drug that effectively controls blood sugar and normalizes healthy body weight. This peptide aids in diabetes treatment and positively affects overall health. As an injectable medication, Semaglutide can be combined with other diabetes treatments, enhancing their effectiveness and improving overall life quality.
The positive effects of Semaglutide include body weight regulation by suppressing appetite and promoting a sense of fullness. It improves blood pressure and cholesterol levels, thus reducing the risk of heart diseases.
-
-
Tirzepatide – 5mg
€ 130,00Tirzepatide is a medicinal product, an injectable analogue of Glucagon, primarily used for treating type 2 diabetes. Due to its molecule containing three lipophilic fundamental mutations, its effect is more prolonged and durable compared to other drugs in this category.
The dynamic mechanism of the Tirzepatide peptide aids patients with type 2 diabetes in controlling their blood sugar levels and reducing the risk of diabetic complications by stimulating the natural function of GLP-1 in the body. Its positive impact on the body includes stimulating insulin production in the pancreas, reducing blood glucose, and enhancing the insulin sensitivity of the body’s cells. Using this peptide creates a sensation of fullness in the body, reducing appetite and preventing the accumulation of fats.
Extensive clinical trials have shown significant improvement in the vitality of the body and a healthy reduction in body weight in patients using the Tirzepatide peptide.